Boston Healthcare grows to meet increasing global demand for health
economics and market access support
BOSTON, Oct. 28 /PRNewswire/ -- Boston Healthcare Associates, Inc. today announced the appointment of Adam Barak as Vice President.
Mr. Barak brings 16 years of pricing and reimbursement experience, including the development of global pricing and reimbursement strategies for drugs, medical devices, and diagnostics in a wide range of therapeutic areas including oncology, pulmonary medicine, gastroenterology, cardiovascular medicine, neurology, and critical care.
"Adam's appointment demonstrates Boston Healthcare's continued commitment to expanding the scope and reach of our services," said Joseph Ferrara, President of Boston Healthcare. "His wealth of experience in pricing and reimbursement will strengthen our position internationally, and provide the expertise and leadership we need to serve our clients more effectively worldwide. Adam is a strong addition to the executive management team and an asset to our global strategy."
Mr. Barak joined GlaxoWellcome's International Pricing & Reimbursement
division in 1996. In 1997, Mr. Barak became Head of European Pricing,
managing the regional function and developing international pricing
strategies for four of the seven GlaxoWellcome therapy areas, including
European pricing strategies for CNS, cardiovascular, oncology,
anesthesiology and diabetes drugs. In 2001, Mr. Barak joined Oxford
GlycoSciences as International Pricing and Reimbursement Manager,
developing global pricing, reimbursement, and market access strategy for
Zavesca, the company's first pharmaceutical launch. In 2002, Mr. Barak
established his own consultancy, ABPPC Ltd, and formed a global network of
consultants that provide the international pharmaceutical and health care
community with specialized support for pricing, reimbursement, and market
access. The network covers 22 countries, and is repres
|SOURCE Boston Healthcare Associates, Inc.|
Copyright©2008 PR Newswire.
All rights reserved